Get it on Google Play

AMNEAL receives FDA approval for epinephrine injection vials

December 9, 2025 4:01 PM EST Send to a Friend
Amneal Pharmaceuticals Inc. (NASDAQ: AMRX) announced that the U.S. Food and Drug Administration has approved its epinephrine injection USP, 1 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login